Atrium Therapeutics
RNA
#9437
Rank
โ‚น13.44 B
Marketcap
โ‚น786.19
Share price
-2.26%
Change (1 day)
-81.91%
Change (1 year)

Revenue for Atrium Therapeutics (RNA)

Revenue in 2026 (TTM): โ‚น3.29 Billion

According to Atrium Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น3.43 Billion. In 2025 the company made a revenue of โ‚น1.67 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atrium Therapeutics from 2025 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น3.29 B97.09%
2025 โ‚น1.67 B